Results 171 to 180 of about 13,013 (192)
Some of the next articles are maybe not open access.
Molecular insights of KMT2D and clinical aspects of Kabuki syndrome type 1
Birth Defects Research, 2023AbstractBackgroundKabuki syndrome type 1 (KS1), a rare multisystem congenital disorder, presents with characteristic facial features, intellectual disability, persistent fetal fingertip pads, skeletal abnormalities, and postnatal growth delays. KS1 results from pathogenic variants in the KMT2D gene, which encodes a histone methyltransferase protein ...
Carly S. Golden +2 more
openaire +2 more sources
Immunologic assessment and
Kabuki or Niikawa–Kuroki syndrome (KS) is a rare disorder with multiple malformations and recurrent infections, especially otitis media. This study aimed to investigate the genetic defects in Kabuki syndrome and determine if immune status is related to recurrent otitis media.
J-L, Lin +9 more
openaire +2 more sources
Downregulation of KMT2D suppresses proliferation and induces apoptosis of gastric cancer
Biochemical and Biophysical Research Communications, 2018Histone lysine methyltransferase 2D (KMT2D/MLL2) is a known cancer-related protein; however, its function in gastric cancer (GC) remains uncharacterized. The present study sought to investigate the expression pattern and the role of KMT2D in GC.The expression of KMT2D were evaluated at mRNA and protein levels, while its clinico-pathological value were ...
Wenjun, Xiong +4 more
openaire +2 more sources
Identifying KDM5B as the synthetic lethal target of KMT2D-mutated osteosarcoma
Chemico-Biological InteractionsOsteosarcoma (OS) is a malignant bone tumor that occurs commonly in adolescents or children, previous studies have shown its complex epigenetic signature. Histone methyltransferases KMT2D loss-of-function mutation is common in various types of human cancer. Here we revealed that KMT2D loss promotes malignant phenotypes in osteosarcoma.
Liyu Yang +7 more
openaire +2 more sources
KMT2D Deficiency Drives Lung Squamous Cell Carcinoma and Hypersensitivity to RTK-RAS Inhibition
Cancer Cell, 2023Hua Zhang +2 more
exaly
Proceedings of the National Academy of Sciences of the United States of America, 2023
Govind Bhagat +2 more
exaly
Govind Bhagat +2 more
exaly
KMT2D Deficiency Impairs Super-Enhancers to Confer a Glycolytic Vulnerability in Lung Cancer
Cancer Cell, 2020Chandrashekar R Ambati +2 more
exaly

